TGFB1 and cancer: Recent studies have demonstrated that miR-27a by regulating SMAD2 inhibits tumor growth and migration by interrupting TGF-β signaling, ultimately leading to inhibition of cancer cell proliferation, induction of apoptosis, and decreased tumor cell migration [357].